COMMUNIQUÉS West-GlobeNewswire
-
Ipsen - Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026
22/07/2026 -
Spryte Medical Completes INSYTE Trial Enrollment
22/07/2026 -
Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
22/07/2026 -
OKYO Pharma Announces Purchase of Shares by Chairman
22/07/2026 -
Ipsen - Déclaration rectificative corrigeant la déclaration mensuelle du nombre total d'actions et de droits de vote au 30 juin 2026
22/07/2026 -
NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform
22/07/2026 -
Valneva publiera ses résultats financiers consolidés du premier semestre le 13 août 2026
22/07/2026 -
RAMSAY SANTE : Press Release - Refinancing new steps forward
22/07/2026 -
One Tulsa Physician Manages Hormone Therapy, Peptides and GLP-1 Weight Loss
22/07/2026 -
FDA Takes Further Steps to Remove Outdated Authorizations for Color Additives in Food
22/07/2026 -
RAMSAY SANTE : communiqué de presse - refinancement et prochaines étapes
22/07/2026 -
Cannara Announces Normal Course Issuer Bid
22/07/2026 -
Veraify Launches Groundbreaking AI-Native Security Platform Built for the AI Workforce Era
22/07/2026 -
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors
22/07/2026 -
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
22/07/2026 -
Unnatural Products Appoints Finance Leader Neera Ravindran, M.D., M.B.A., as Chief Financial Officer
22/07/2026 -
Oncotelic Announces Peer-Reviewed Publication Validating Deciparticle™ Technology Supporting the Ongoing Clinical Development of Sapu003 (IV everolimus)
22/07/2026 -
Exubrion Therapeutics Promotes Gregory Taglialatela to Chief Commercial Officer
22/07/2026 -
Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease
22/07/2026
Pages